FDA Approves Philip Morris's Zyn as Less Harmful Than Cigarettes

The U.S. Food and Drug Administration (FDA) has authorized Philip Morris International to use marketing claims that its tobacco-free nicotine pouch, Zyn, is less harmful than traditional cigarettes. This decision allows the company to promote the product as 'less harmful.' The FDA's approval will enable Zyn to be positioned as a lower-risk alternative for smokers. Philip Morris plans to launch advertising campaigns highlighting the product's potential to reduce health risks following this decision. The regulatory agency stated that Zyn contains fewer toxic substances compared to cigarettes and therefore poses less harm to consumers. However, the FDA also emphasized that the product is not entirely risk-free and may lead to nicotine addiction. This development is seen as part of Philip Morris's strategy to shift toward non-cigarette products. The company has previously received similar approvals for heated tobacco products like IQOS. This is not investment advice.